Antibiotic Compound of Symbiotic Bacillus sp1 (HA1) from Marine Sponge Haliclona fascigera

Main Article Content

Wiza Leila Puspita Sari
Deddi Prima Putra
Dian Handayani

Abstract

Symbiotic bacteria are bacteria that live within a host tissue and do not harm the host itself. These bacteria can produce various bioactive compounds such as antibacterial compounds. This study aimed to isolate the antibiotic compounds from ethyl acetate extract of symbiotic bacteria Bacillus sp.1 (HA1) of marine sponge Haliclona fascigera. Bacterial cultivation was performed on Nutrient Broth medium using incubator shaker at 150 rpm at 37ºC for 24 hours. The isolation of antibiotic compound was done by column chromatography method and testing of antibacterial activity was conducted by agar diffusion method. The study revealed 2 pure compounds W1 and W2. The compound W1 (10.8 mg) was soluble in the ethyl acetate and methanol but was difficult to dissolve in n-hexane. This compound could inhibit the growth of pathogenic bacteria Staphylococcus aureus ATCC 25923 with 1% of minimum inhibition concentration (MIC). While the compound W2 (2.3 mg) was soluble in dichloromethane and methanol but was difficult to dissolve in n-hexane. The W2 compound could not inhibit the growth of Staphylococcus aureus ATCC 25923.

Article Details

How to Cite
Sari, W. L. P., Putra, D. P., & Handayani, D. (2017). Antibiotic Compound of Symbiotic Bacillus sp1 (HA1) from Marine Sponge Haliclona fascigera. Jurnal Sains Farmasi & Klinis, 3(2), 128–133. https://doi.org/10.29208/jsfk.2017.3.2.138
Section
Research Articles

References

World Health Organization. (2017). The top 10 causes of the death. Geneva.

Aliero, A., Aliero, B. L., & Buhari, U. (2008). Preliminary phytochemical and antibacterial screening of Scadoxus multiflorus. Int J Pure Appl Sci, 2(4), 13-17.

Andayani, S. G. D., Linar, Z. U., Kardono, L. B. S., & Hanafi, M. (2006). Antibotika baru dari Actinomycetes dan Jamur. Prosiding Seminar Nasional Himpunan Kimia Indonesia. Departemen Kimia FMIPA IPB.

Zhang, Y., Mu, J., Feng, Y., Kang, Y., Zhang, J., Gu, P. J., ... & Zhu, Y. H. (2009). Broad-spectrum antimicrobial epiphytic and endophytic fungi from marine organisms: isolation, bioassay and taxonomy. Marine drugs, 7(2), 97-112.

Paz, Z., Komon-Zelazowska, M., Druzhinina, I. S., Aveskamp, M. M., Shnaiderman, A., Aluma, Y., ... & Yarden, O. (2010). Diversity and potential antifungal properties of fungi associated with a Mediterranean sponge. Fungal Diversity, 42(1), 17-26.

Saleem, M., Ali, M. S., Hussain, S., Jabbar, A., Ashraf, M., & Lee, Y. S. (2007). Marine natural products of fungal origin. Natural product reports, 24(5), 1142-1152.

Rateb, M. E., & Ebel, R. (2011). Secondary metabolites of fungi from marine habitats. Natural Product Reports, 28(2), 290-344.

Samuel, P., Prince, L., & Prabakaran, P. (2011). Ocean: the inviolated source of pharmaceutical leads and drug metabolites. World J. Sci. Technol, 1(10), 74-91.

Radjasa, O. K., Sabdono, A., Junaidi, J., & Zocchi, E. (2007). Richness of Secondary Metabolite-Producing Marine Bacteria Associated with Sponge Hatictona sp.

Thomas, T. R. A., Kavlekar, D. P., & LokaBharathi, P. A. (2010). Marine drugs from sponge-microbe association—A review. Marine Drugs, 8(4), 1417-1468..

Faulkner, D. J. (1997). Marine natural products. Natural Product Reports, 14(3), 259-302.

Taylor, M. W., Radax, R., Steger, D., & Wagner, M. (2007). Sponge-associated microorganisms: evolution, ecology, and biotechnological potential. Microbiology and Molecular Biology Reviews, 71(2), 295-347.

Febrianto, R.E. (2014.) Penapisan Aktivitas Antimikroba Bakteridari Spon Laut Haliclona fascigera Asal Perairan Pulau Mandeh Pesisir Selatan Sumatra Barat (Skripsi). Fakultas Farmasi Universitas Andalas.

Yu, L. L., Li, Z. Y., Peng, C. S., Li, Z. Y., & Guo, Y. W. (2009). Neobacillamide A, a Novel Thiazoleâ€Containing Alkaloid from the Marine Bacterium Bacillus vallismortis C89, Associated with South China Sea Sponge Dysidea avara. Helvetica Chimica Acta, 92(3), 607-612.

Proksch, P., Edrada, R., & Ebel, R. (2002). Drugs from the seas-current status and microbiological implications. Applied Microbiology and Biotechnology, 59(2), 125-134.